blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3057604

EP3057604 - NANOPARTICLE COMPOSITIONS AND METHODS AS CARRIERS OF NUTRACEUTICAL FACTORS ACROSS CELL MEMBRANES AND BIOLOGICAL BARRIERS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  15.04.2022
Database last updated on 16.11.2024
FormerThe patent has been granted
Status updated on  10.05.2021
FormerGrant of patent is intended
Status updated on  10.12.2020
FormerExamination is in progress
Status updated on  20.07.2018
FormerRequest for examination was made
Status updated on  07.01.2018
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT
published on 09.10.2024  [2024/41]
Applicant(s)For all designated states
Nanosphere Health Sciences Inc.
488-1090 West Georgia St.
Vancouver, BC V6E 3V7 / CA
[2021/22]
Former [2016/34]For all designated states
Nanosphere Health Sciences, LLC
8400 E. Crescent Parkway Suite 600
Greenwood Village, CO 80111 / US
Inventor(s)01 / KAUFMAN, Richard, Clark
1801 Dewey St.
Santa Monica, CA 90405 / US
 [2016/34]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[2021/23]
Former [2016/34]Clegg, Richard Ian, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
Application number, filing date14854788.814.10.2014
[2016/34]
WO2014US60551
Priority number, dateUS201361890773P14.10.2013         Original published format: US 201361890773 P
[2016/34]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015057751
Date:23.04.2015
Language:EN
[2015/16]
Type: A1 Application with search report 
No.:EP3057604
Date:24.08.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 23.04.2015 takes the place of the publication of the European patent application.
[2016/34]
Type: B1 Patent specification 
No.:EP3057604
Date:09.06.2021
Language:EN
[2021/23]
Search report(s)International search report - published on:US23.04.2015
(Supplementary) European search report - dispatched on:EP02.05.2017
ClassificationIPC:A61K9/51, A61K9/00, A61K31/185, A61K31/198, A61K31/202, A61K33/30
[2020/50]
CPC:
A61K9/5192 (EP,US); A61K31/047 (EP,US); A61K31/05 (EP,US);
A61K31/07 (EP,US); A61K31/122 (EP,US); A61K31/185 (EP,US);
A61K31/198 (EP,US); A61K31/202 (EP,US); A61K31/23 (EP,US);
A61K31/352 (EP,US); A61K31/353 (EP,US); A61K31/355 (EP,US);
A61K31/375 (EP,US); A61K31/385 (EP,US); A61K31/4172 (EP,US);
A61K31/4415 (EP,US); A61K31/675 (EP,US); A61K31/685 (EP,US);
A61K31/7034 (EP,US); A61K31/728 (EP,US); A61K33/06 (EP,US);
A61K33/24 (EP,US); A61K33/30 (EP,US); A61K36/00 (EP,US);
A61K36/16 (US); A61K36/185 (US); A61K36/28 (US);
A61K36/286 (US); A61K36/82 (US); A61K38/063 (EP,US);
A61K9/0014 (EP,US); A61K9/0048 (EP,US); A61K9/0053 (EP,US);
A61K9/006 (EP,US); A61K9/127 (EP,US); A61K9/1277 (US);
A61K9/5123 (EP,US) (-)
C-Set:
A61K36/00, A61K2300/00 (EP,US)
Former IPC [2016/34]A61K38/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/34]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:NANOPARTIKELZUSAMMENSETZUNGEN UND -VERFAHREN ALS TRÄGER VON NUTRAZEUTISCHEN FAKTOREN DURCH ZELLMEMBRANEN UND BIOLOGISCHE BARRIEREN[2016/34]
English:NANOPARTICLE COMPOSITIONS AND METHODS AS CARRIERS OF NUTRACEUTICAL FACTORS ACROSS CELL MEMBRANES AND BIOLOGICAL BARRIERS[2016/34]
French:COMPOSITIONS DE NANOPARTICULES ET PROCÉDÉS UTILISÉS EN TANT QUE SUPPORTS DE FACTEURS NUTRACEUTIQUES À TRAVERS DES MEMBRANES CELLULAIRES ET DES BARRIÈRES BIOLOGIQUES[2016/34]
Entry into regional phase19.04.2016National basic fee paid 
19.04.2016Search fee paid 
19.04.2016Designation fee(s) paid 
19.04.2016Examination fee paid 
Examination procedure19.04.2016Examination requested  [2016/34]
08.01.2018Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
14.03.2018Amendment by applicant (claims and/or description)
24.07.2018Despatch of a communication from the examining division (Time limit: M06)
04.02.2019Reply to a communication from the examining division
13.05.2019Despatch of a communication from the examining division (Time limit: M04)
23.09.2019Reply to a communication from the examining division
21.01.2020Despatch of a communication from the examining division (Time limit: M06)
31.07.2020Reply to a communication from the examining division
11.12.2020Communication of intention to grant the patent
19.04.2021Fee for grant paid
19.04.2021Fee for publishing/printing paid
19.04.2021Receipt of the translation of the claim(s)
Opposition(s)10.03.2022No opposition filed within time limit [2022/20]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
14.03.2018Request for further processing filed
14.03.2018Full payment received (date of receipt of payment)
Request granted
22.03.2018Decision despatched
Fees paidRenewal fee
11.10.2016Renewal fee patent year 03
11.10.2017Renewal fee patent year 04
11.10.2018Renewal fee patent year 05
15.10.2019Renewal fee patent year 06
14.10.2020Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU14.10.2014
AL09.06.2021
AT09.06.2021
CY09.06.2021
CZ09.06.2021
EE09.06.2021
ES09.06.2021
FI09.06.2021
HR09.06.2021
IT09.06.2021
LT09.06.2021
LV09.06.2021
MC09.06.2021
MK09.06.2021
MT09.06.2021
RO09.06.2021
RS09.06.2021
SI09.06.2021
SK09.06.2021
SM09.06.2021
TR09.06.2021
BG09.09.2021
NO09.09.2021
GR10.09.2021
IS09.10.2021
PT11.10.2021
LU14.10.2021
BE31.10.2021
[2024/41]
Former [2024/29]HU14.10.2014
AL09.06.2021
AT09.06.2021
CY09.06.2021
CZ09.06.2021
EE09.06.2021
ES09.06.2021
FI09.06.2021
HR09.06.2021
IT09.06.2021
LT09.06.2021
LV09.06.2021
MC09.06.2021
MK09.06.2021
RO09.06.2021
RS09.06.2021
SI09.06.2021
SK09.06.2021
SM09.06.2021
TR09.06.2021
BG09.09.2021
NO09.09.2021
GR10.09.2021
IS09.10.2021
PT11.10.2021
LU14.10.2021
BE31.10.2021
Former [2024/22]HU14.10.2014
AL09.06.2021
AT09.06.2021
CY09.06.2021
CZ09.06.2021
EE09.06.2021
ES09.06.2021
FI09.06.2021
HR09.06.2021
IT09.06.2021
LT09.06.2021
LV09.06.2021
MC09.06.2021
MK09.06.2021
RO09.06.2021
RS09.06.2021
SI09.06.2021
SK09.06.2021
SM09.06.2021
BG09.09.2021
NO09.09.2021
GR10.09.2021
IS09.10.2021
PT11.10.2021
LU14.10.2021
BE31.10.2021
Former [2023/30]HU14.10.2014
AL09.06.2021
AT09.06.2021
CY09.06.2021
CZ09.06.2021
EE09.06.2021
ES09.06.2021
FI09.06.2021
HR09.06.2021
IT09.06.2021
LT09.06.2021
LV09.06.2021
MC09.06.2021
RO09.06.2021
RS09.06.2021
SI09.06.2021
SK09.06.2021
SM09.06.2021
BG09.09.2021
NO09.09.2021
GR10.09.2021
IS09.10.2021
PT11.10.2021
LU14.10.2021
BE31.10.2021
Former [2023/29]HU14.10.2014
AL09.06.2021
AT09.06.2021
CZ09.06.2021
EE09.06.2021
ES09.06.2021
FI09.06.2021
HR09.06.2021
IT09.06.2021
LT09.06.2021
LV09.06.2021
MC09.06.2021
RO09.06.2021
RS09.06.2021
SI09.06.2021
SK09.06.2021
SM09.06.2021
BG09.09.2021
NO09.09.2021
GR10.09.2021
IS09.10.2021
PT11.10.2021
LU14.10.2021
BE31.10.2021
Former [2022/36]AL09.06.2021
AT09.06.2021
CZ09.06.2021
EE09.06.2021
ES09.06.2021
FI09.06.2021
HR09.06.2021
IT09.06.2021
LT09.06.2021
LV09.06.2021
MC09.06.2021
RO09.06.2021
RS09.06.2021
SI09.06.2021
SK09.06.2021
SM09.06.2021
BG09.09.2021
NO09.09.2021
GR10.09.2021
IS09.10.2021
PT11.10.2021
LU14.10.2021
BE31.10.2021
Former [2022/35]AL09.06.2021
AT09.06.2021
CZ09.06.2021
EE09.06.2021
ES09.06.2021
FI09.06.2021
HR09.06.2021
LT09.06.2021
LV09.06.2021
MC09.06.2021
RO09.06.2021
RS09.06.2021
SI09.06.2021
SK09.06.2021
SM09.06.2021
BG09.09.2021
NO09.09.2021
GR10.09.2021
IS09.10.2021
PT11.10.2021
LU14.10.2021
BE31.10.2021
Former [2022/33]AL09.06.2021
AT09.06.2021
CZ09.06.2021
EE09.06.2021
ES09.06.2021
FI09.06.2021
HR09.06.2021
LT09.06.2021
LV09.06.2021
MC09.06.2021
RO09.06.2021
RS09.06.2021
SI09.06.2021
SK09.06.2021
SM09.06.2021
BG09.09.2021
NO09.09.2021
GR10.09.2021
IS09.10.2021
PT11.10.2021
BE31.10.2021
Former [2022/29]AL09.06.2021
AT09.06.2021
CZ09.06.2021
EE09.06.2021
ES09.06.2021
FI09.06.2021
HR09.06.2021
LT09.06.2021
LV09.06.2021
RO09.06.2021
RS09.06.2021
SI09.06.2021
SK09.06.2021
SM09.06.2021
BG09.09.2021
NO09.09.2021
GR10.09.2021
IS09.10.2021
PT11.10.2021
Former [2022/26]AL09.06.2021
AT09.06.2021
CZ09.06.2021
EE09.06.2021
ES09.06.2021
FI09.06.2021
HR09.06.2021
LT09.06.2021
LV09.06.2021
RO09.06.2021
RS09.06.2021
SK09.06.2021
SM09.06.2021
BG09.09.2021
NO09.09.2021
GR10.09.2021
IS09.10.2021
PT11.10.2021
Former [2022/10]AT09.06.2021
CZ09.06.2021
EE09.06.2021
ES09.06.2021
FI09.06.2021
HR09.06.2021
LT09.06.2021
LV09.06.2021
RO09.06.2021
RS09.06.2021
SK09.06.2021
SM09.06.2021
BG09.09.2021
NO09.09.2021
GR10.09.2021
IS09.10.2021
PT11.10.2021
Former [2022/09]AT09.06.2021
CZ09.06.2021
ES09.06.2021
FI09.06.2021
HR09.06.2021
LT09.06.2021
LV09.06.2021
RO09.06.2021
RS09.06.2021
SK09.06.2021
SM09.06.2021
BG09.09.2021
NO09.09.2021
GR10.09.2021
PT11.10.2021
Former [2022/08]AT09.06.2021
CZ09.06.2021
ES09.06.2021
FI09.06.2021
HR09.06.2021
LT09.06.2021
LV09.06.2021
RS09.06.2021
SM09.06.2021
BG09.09.2021
NO09.09.2021
GR10.09.2021
Former [2022/07]AT09.06.2021
FI09.06.2021
HR09.06.2021
LT09.06.2021
LV09.06.2021
RS09.06.2021
SM09.06.2021
BG09.09.2021
NO09.09.2021
GR10.09.2021
Former [2021/51]FI09.06.2021
HR09.06.2021
LT09.06.2021
LV09.06.2021
RS09.06.2021
BG09.09.2021
NO09.09.2021
GR10.09.2021
Former [2021/49]FI09.06.2021
HR09.06.2021
LT09.06.2021
LV09.06.2021
BG09.09.2021
NO09.09.2021
GR10.09.2021
Former [2021/47]FI09.06.2021
LT09.06.2021
BG09.09.2021
Former [2021/46]FI09.06.2021
LT09.06.2021
Documents cited:Search[X]WO2008010788  (UNIV MASSACHUSETTS LOWELL [US], et al) [X] 1-15* examples 4,11 *;
 [X]WO2010008762  (COMSTOCK ROBERT LAWRENCE [SG], et al) [X] 1-15 * examples 1,4 *
International search[Y]US2003096000  (SOLIS ROSA MARIA [US], et al);
 [Y]WO2005063665  (AMERICAN BIOSCIENCE INC [US], et al);
 [Y]WO2012003003  (COVARIS INC [US], et al);
 [Y]US2012093931  (MCGINNIS JAMES F [US], et al);
 [X]WO2012066334  (ISIS INNOVATION [GB], et al);
 [Y]US2012321670  (DOSHI MANISH [IN], et al);
 [Y]WO2013105101  (DEPT OF BIOTECHNOLOGY INDIA [IN], et al);
 [X]  - KAUFMAN, "Nanosphere delivery systems. Methods for overcoming bioavailability limitations.", NANOSPHERE DELIVERY SYSTEMS, (201308), pages 1 - 8, XP055335830
Examination   - Chaturvedi, "Production Techniques of Lipid Nanoparticles: A Review", Research Journal of Pharmaceutical, Biological and Chemical Sciences, IN, (20120701), ISSN 0975-8585, pages 525 - 541, XP055586265
    - P Ekambaram ET AL, "SOLID LIPID NANOPARTICLES: A REVIEW", Sci. Revs. Chem. Commun, (20120101), pages 22 - 25, URL: https://www.tsijournals.com/articles/solid-lipid-nanoparticles-a-review.pdf, XP055586251
    - SURAJIT DAS ET AL, "Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery", AAPS PHARMSCITECH, SPRINGER NEW YORK LLC, US, (20101221), vol. 12, no. 1, doi:10.1208/S12249-010-9563-0, ISSN 1530-9932, pages 62 - 76, XP019891283

DOI:   http://dx.doi.org/10.1208/s12249-010-9563-0
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.